Keywords: Takeda, Nycomed, M&A denial

Takeda denies it is in talks to buy Nycomed

Article | 13 May 2011

Print This

Takeda Pharmaceutical (TSE: 4502), Japan’s largest drugmaker, has emphatically denied that it is in advanced talks to acquire independent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in